SensoDetect AB: SensoDetect addresses recent share-price volatility and reaffirms accelerating execution, market positioning and strategic financial direction

-----------------------------------------------------------------------------------------------------------------------------------------------

Execution is accelerating across core markets

Over recent months, SensoDetect has materially strengthened its operational platform and commercial readiness by

• activating the AI-enhanced BERA platform within the China JV,
• advancing structured cooperation with hospitals, schools, universities and industry groups,
• preparing the JV-built prototype for transfer to Sweden for final AI integration,
• elevating engagement with national health leadership in Saudi Arabia,
• and consolidating Sweden's central role as the Company's global AI & quality hub.

These developments significantly elevate SensoDetect's market readiness and commercial potential heading into 2026.

-----------------------------------------------------------------------------------------------------------------------------------------------

China - positioned for structured scale

The Company's China strategy is now moving from foundation to controlled acceleration.

Core pillars now advancing

• prototype transfer to Sweden for calibration & AI upgrade,
• expansion of clinical partnerships across regions,
• deepening cooperation with private school systems,
• structured dialogues with industrial partners incl. aviation & security,
• and the establishment of AI collaboration with leading universities.

The Company's leadership in China underscores confidence, momentum and strategic alignment.

-----------------------------------------------------------------------------------------------------------------------------------------------

Saudi Arabia - progressing toward national deployment

Discussions with leading healthcare authorities in Saudi Arabia are progressing with a shared strategic objective

• to enable structured, nationwide, objective neurodevelopmental screening.

SensoDetect views Saudi Arabia as a central market within its global scale strategy.

-----------------------------------------------------------------------------------------------------------------------------------------------

Financial trajectory strengthening

SensoDetect continues to execute with a strict performance-driven financial philosophy based on

• disciplined cost structure,
• expanding partnership-based revenue,
• and increasing operational throughput.

Internal modeling signals a strengthening financial trend-line into 2026, with momentum expected to increase further into 2027.

-----------------------------------------------------------------------------------------------------------------------------------------------

CEO Statement - PA Hedin

"We are executing a very clear strategy. While the market has been volatile in the short term, our direction, our milestones, and our momentum have never been clearer. Across China, Saudi Arabia and Sweden, SensoDetect is building a scalable, high-integrity commercial platform. 2026 is designed as the year where structures convert into commercial outcomes, and 2027 is designed as the acceleration phase. I want to thank our long-term shareholders for their confidence. We are entering this next phase determined, focused and with a long-term mindset."

-----------------------------------------------------------------------------------------------------------------------------------------------

Forward direction

SensoDetect is sharply focused on executing the next phase of its growth plan:

• accelerated implementation in China,
• structured deployment in Saudi Arabia,
• strengthened global AI & quality function in Sweden,
• disciplined scale-up toward commercial inflection.

SensoDetects management firmly believes the Company's fundamental value will become increasingly visible as these initiatives convert into measurable commercial progress.